Concepedia
Statistics
Publications
17
Citations
1.2K
H-Index
14
Active since
2002
Affiliations
Leidos (United States)(Current)
Frederick National Laboratory for Cancer Research
National Cancer Institute
Vanderbilt University
National Institutes of Health
Gordon M. Stott is an author at Leidos (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.
Publications per year
2002–2025
Zebrafish as a Model Organism for the Identification and Characterization of Drugs and Genes Affecting p53 Signaling
Ulrike Langheinrich, Elisabeth Hennen, Gordon M. Stott et al. · Current Biology · 2002 · 380 citations · Full text
Medicine, Molecular Biology, Oncology +11
Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH)
Ganesha Rai, Kyle R. Brimacombe, Bryan T. Mott et al. · Journal of Medicinal Chemistry · 2017 · 154 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma
Choh Yeung, Anna E. Gibson, Sameer H. Issaq et al. · Cancer Research · 2019 · 130 citations · Full text
Medicine, Oncology, Pharmacology +14
Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy
Nobu Oshima, Ryo Ishida, Shun Kishimoto et al. · Cell Reports · 2020 · 122 citations · Full text
Medicine, Oncology, Pharmacology +17
Discovery of XL413, a potent and selective CDC7 inhibitor
Elena S. Koltun, Amy Lew Tsuhako, David S. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 92 citations · Full text
Pharmacy, Medicinal Chemistry, Molecular Biology +9
1–5 of 17